GLP-3 RT (10mg)

Name: GLP-3 RT (10mg)
Brand: peptide limited
SKU: PEPTIDE-FF7A33
Price: 252.00 EUR
Availability: InStock
Rating: 5.0 (1 reviews)

≥97% (HPLC) Purity

HPLC/MS Verified

Free EU Shipping

Triple agonist (GLP-1/GIP/Glucagon) for metabolic research.

Mechanism: GLP-1 (appetite), GIP (insulin sensitivity), Glucagon (thermogenesis).

Applications: Obesity, NAFLD/NASH, metabolic syndrome.

Protocol: Reconstitute 2ml BAC water. Store -20°C. Do not vortex.

Research Overview

The first triple-incretin receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. Phase 2 data demonstrated the largest weight reductions reported for any anti-obesity molecule, positioning it as a next-generation metabolic research compound.

Origin: Triple GIP/GLP-1/glucagon receptor agonist by Eli Lilly

Mechanism of Action

GIP receptor agonism

GLP-1 receptor agonism

Glucagon receptor agonism (energy expenditure)

Hepatic lipid metabolism enhancement

Appetite suppression via CNS pathways

Primary Research Areas

Obesity

NASH

Metabolic syndrome

Triple-incretin signaling

Energy expenditure

Key Published Findings

Phase 2: up to 24.2% body weight reduction at 48 weeks (highest reported for any molecule)

Glucagon component uniquely increases energy expenditure

Significant reduction in liver fat content in NAFLD models

Research Protocol

Commonly studied routes: Subcutaneous. Reconstitute with bacteriostatic water. Consult published literature for dose ranges; use our Peptide Calculator for volumetric preparation.

Storage

2-8°C

Important Notice

Retatrutide (10mg) is supplied for laboratory research use only (RUO). Not for human or veterinary use, diagnostics, or therapeutics.

Synthesized for strict analytical consistency. Verified via HPLC/MS.View Quality Standards →

Sequence

Modified triple incretin agonist

Mass Spec

Confirmed Identity

GLP-3 RT (10mg) is a research compound in the Peptides category. Triple GIP/GLP-1/glucagon receptor agonist by Eli Lilly

No. All products on peptide limited are supplied strictly for laboratory and research use only (RUO). They are not intended for human or veterinary use, diagnostics, or therapeutics.

Batches are verified using analytical methods such as HPLC and Mass Spectrometry to confirm identity and assess purity. We publish COA documentation when available and can provide batch documentation on request.

Store lyophilized material sealed, protected from light and moisture, at -20°C for long-term stability. After reconstitution, minimize freeze-thaw cycles and use sterile handling protocols.

COAs are available for many batches. If a COA link is not shown on this page, please contact support to request the latest documentation for your batch.

This product is supplied at ≥97% (HPLC) purity as determined by HPLC analysis. Identity is confirmed via Mass Spectrometry (MS).

Purity (HPLC)	≥97% (HPLC)
CAS Number	2381089-83-2

Technical Specifications

From the Peptide Explorer

Key Mechanisms

Primary Research Areas

Key Research Findings

Research Overview

Mechanism of Action

Primary Research Areas

Key Published Findings

Research Protocol

Storage

Important Notice

Research Specifications

Handling & Storage

Frequently Asked Questions

Verified Research Reviews

Log Research Findings

Related Research Compounds

Oxytocin Acetate Nasal Spray (10mg)

SNAP-8 (10mg)

KPV (5mg)

VIP (5mg)